Healthcare AI Exits Pilot Phase, Enters Production Deployment
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- Fed: Nine Of 18 FOMC Participants Pencil In 2026 Rate Hike
- Delta Air Lines (DAL) Raises Quarterly Dividend 14.7% to $0.2150; 1% Yield
- ICC sets July 24 vote on whether to remove chief prosecutor Karim Khan, WSJ reports
BofA Securities on Doximity Inc (DOCS): 'No shift from DTC, but HCP growth is accelerating'
December 16, 2025 6:00 AM ESTBofA Securities analyst Allen Lutz reiterated a Buy rating and $82.00 price target on Doximity Inc (NYSE: DOCS).
The analyst comments "Yesterday, we hosted a conference call on pharma ad budgets with two industry executives, Andrew McLean, and Stuart Klein (bios below).... More
